Rapid synthesis method of isomyosmine

By using nicolycoaldehyde and tert-butylsulfinamide as raw materials, isomermin was prepared through three-step reactions, which solved the long and safe and environmentally friendly problems of isomermin synthesis in the existing technology, and achieved safe and environmentally friendly high efficiency Production.

CN118994099APending Publication Date: 2024-11-22NANTONG YIHAO PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411105959.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The existing synthetic route of isomesmin is restricted by safety and environmental protection pressure, and the production capacity cannot be expanded, and there are problems such as long routes and complex separation and purification.

Method used

Using nicolycoaldehyde and tert-butylsulfinamide as raw material and dichloromethane as solvent, the reaction of pyridinium toluenesulfonate was made to produce imine intermediate 1, and then through Grignard reaction, intermediate 2, hydrochloric acid-dioxide Under the conditions of hexacycles, the protective group is removed and the ring is closed to obtain isomemazine. The reaction takes only 3 steps, the conditions are mild, and it is suitable for industrial production.

Benefits of technology

It realizes the rapid synthesis of imesmin, the route is safer and more environmentally friendly, facilitates industrial production, and simplifies the process flow.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004990814910000021
    Figure BDA0004990814910000021
  • Figure BDA0004990814910000031
    Figure BDA0004990814910000031
  • Figure FDA0004990814900000011
    Figure FDA0004990814900000011
Patent Text Reader

Abstract

The invention relates to the technical field of organic synthesis, in particular to a rapid synthesis method of isomyosmine. The preparation method comprises the following steps: taking nicotinaldehyde and tert-butyl sulfinamide as raw materials, taking dichloromethane as a solvent, reacting under the action of pyridinium p-toluenesulfonate to prepare an imine intermediate I, then performing Grignard reaction to obtain an intermediate II, and removing a protecting group and closing a ring under the condition of hydrochloric acid-dioxane to obtain the isomyosmine. According to the provided rapid synthesis method of the isomyosmine, the reaction only needs three steps, the conditions are mild, the route is safer and more environmentally friendly, and industrial production is facilitated.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of organic synthesis, in particular to a rapid synthesis method of isomycesmine. Background Art

[0002] Isomysamine can help restore the normal function of endogenous species by blocking the production of peroxides and / or other reactive oxygen species (ROS) in the microenvironment or otherwise reducing the concentration of hydrogen peroxide and / or other reactive oxygen species (ROS) in the microenvironment. Changing the tumor microenvironment can also improve the effects of other cancer therapies such as chemotherapy. As long as the presence of hydrogen peroxide and / or other ROS can be the cause of tumorigenesis, isomysamine can also be effective in preventing or delaying tumor onset.

[0003] The current synthesis routes of isomycesmine cannot be expanded due to safety and environmental pressures, and all have problems such as long routes and complex separation and purification.

[0004] Based on this, the present invention provides a rapid synthesis method of isomycesmine to solve the above-mentioned technical problems! Summary of the invention

[0005] The object of the present invention is to provide a rapid synthesis method of isomycamine. In the present invention, nicotinaldehyde and tert-butylsulfenamide are used as raw materials, dichloromethane is used as a solvent, and under the action of pyridinium p-toluenesulfonate, an imine intermediate 1 is reacted, and then an intermediate 2 is obtained by Grignard reaction. The protecting group is removed and the ring is closed under the conditions of hydrochloric acid-dioxane to obtain isomycamine. The rapid synthesis method only requires 3 steps and the conditions are mild, so that the route is safer, more environmentally friendly, and convenient for industrial production.

[0006] To achieve the above object, the present invention provides the following technical solutions:

[0007] The present invention provides a rapid synthesis method of isomycesmine, comprising the following steps:

[0008] S1, dissolving tert-butylsulfenamide in a solvent, adding a desiccant thereto, then adding an additive and nicotinaldehyde, stirring the mixture at room temperature, filtering the resulting reaction mixture through diatomaceous earth, washing with dichloromethane, and concentrating to obtain a yellow oily intermediate 1;

[0009] S2, the ground magnesium chips are placed in a round-bottom flask, tetrahydrofuran and 2-(2'-bromoethyl)-1,3-dioxane solution are added, and intermittent heating and a catalytic amount of iodine are added to initiate the reaction, and the mixture is stirred at room temperature for 1 to 2 hours to obtain a Grignard reagent, and then the Grignard reagent is added to the intermediate solution at -40°C, and the mixture is stirred at -40°C for 10 to 15 hours. After the reaction is completed, the mixture is quenched and extracted, and concentrated to obtain the intermediate 2;

[0010] S3, add 4N hydrochloric acid-dioxane solution to the intermediate 2, react at room temperature for 5 to 10 hours, quench with sodium bicarbonate, extract with dichloromethane, combine the organic phases, dry with anhydrous sodium sulfate, concentrate and purify by column chromatography to obtain isomycesine as a yellow oily liquid;

[0011] The chemical structural formula of the isomycesmine is as follows:

[0012]

[0013] 2. The rapid synthesis method of isomycesmine according to claim 1, characterized in that, in step S1, the stirring reaction time is 15 to 20 hours.

[0014] 3. The rapid synthesis method of isomycesmine according to claim 1, characterized in that in step S1, the solvent is dichloromethane.

[0015] 4. The rapid synthesis method of isomycesmine according to claim 1, characterized in that in step S1, the desiccant is anhydrous magnesium sulfate.

[0016] 5. The rapid synthesis method of isomycesmine according to claim 1, characterized in that in step S1, the desiccant is anhydrous magnesium sulfate.

[0017] 6. The method for rapid synthesis of isomycesmine according to claim 1, characterized in that in step S1, the additive is pyridinium p-toluenesulfonate.

[0018] 7. The method for rapid synthesis of isomycesmine according to claim 1, characterized in that in step S2, the intermediate liquid is prepared by mixing intermediate 1 and tetrahydrofuran.

[0019] 8. The method for rapid synthesis of isomycesmine according to claim 1, characterized in that in step S2, the molar ratio of the Grignard reagent to the intermediate solution is 3:1.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] In the present invention, nicotinaldehyde and tert-butylsulfenamide are used as raw materials, dichloromethane is used as solvent, and under the action of pyridinium p-toluenesulfonate, an imine intermediate 1 is obtained by reaction, and then an intermediate 2 is obtained by Grignard reaction, and the protecting group is removed and the ring is closed under the conditions of hydrochloric acid-dioxane to obtain isomycmine; the provided rapid synthesis method of isomycmine only requires 3 steps, and the conditions are mild, so that the route is safer, environmentally friendly, and convenient for industrial production. The rapid synthesis method provided by the present invention has broad application prospects and is worth promoting. DETAILED DESCRIPTION

[0022] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0023] Example

[0024] In this example, nicotinaldehyde and tert-butylsulfenamide are used as raw materials, dichloromethane is used as solvent, and pyridinium p-toluenesulfonate is used to react to obtain an imine intermediate 1, and then a Grignard reaction is performed to obtain an intermediate 2. The protecting group is removed under the conditions of hydrochloric acid-dioxane and the ring is closed to obtain isomycesmine. The process route is as follows:

[0025]

[0026] The specific process is as follows:

[0027] Step 1: Synthesis of (E)-2-methyl-N-(pyridin-3-ylmethylene)propane-2-sulfenamide

[0028] Tert-butylsulfenamide (4.0 g, 33.0 mmol) was dissolved in dry dichloromethane (20 mL) in a 100 mL dried round-bottom flask, anhydrous magnesium sulfate (20.0 mg, 165.1 mmol) was added thereto, followed by pyridinium p-toluenesulfonate (420.0 mg, 1.7 mmol), liquid nicotinaldehyde (3.5 g, 33.0 mmol). The mixture was stirred at room temperature for 15 hours. The reaction mixture was filtered through diatomaceous earth, washed with dichloromethane, and concentrated to give a yellow oily liquid INT1, i.e. (E)-2-methyl-N-(pyridin-3-ylmethylene)propane-2-sulfenamide (6.8 g, 98% yield).

[0029] Step 2: Synthesis of N-(3-(1,3-dioxane-2-yl)-1-(pyridin-3-yl)propyl)-2-methylpropane-2-sulfenamide

[0030] Freshly ground magnesium turnings (6.24 g, 256.8 mmol) were placed in a 500 mL round-bottom flask, and tetrahydrofuran (20 mL) and 2-(2'-bromoethyl)-1,3-dioxane (6.48 mL, 85.6 mmol) solution were added while heating intermittently and adding a catalytic amount of iodine to initiate the reaction. The mixture was stirred at room temperature for 1 hour. To a solution of the intermediate, i.e., (E)-2-methyl-N-(pyridin-3-ylmethylene)propane-2-sulfinamide (3.6 g, 17.2 mmol) in tetrahydrofuran (20 mL), the above-mentioned Grignard reagent was added at -40°C and stirred at this temperature for 10 hours. After the reaction was completed, saturated ammonium chloride (20 mL) was added to quench the reaction, and the mixture was extracted with ethyl acetate (3*30 mL), dried over anhydrous sodium sulfate, concentrated and purified by column chromatography (dichloromethane: methanol = 10: 1) to give INT2, i.e., N-(3-(1,3-dioxane-2-yl)-1-(pyridin-3-yl)propyl)-2-methylpropane-2-sulfinamide (3.7 g, yield 86%).

[0031] Step 3: Synthesis of Isomysamine

[0032] 4N hydrochloric acid-dioxane solution (5 mL) was added to N-(3-(1,3-dioxane-2-yl)-1-(pyridin-3-yl)propyl)-2-methylpropane-2-sulfinamide (3.3 g, 10.0 mmol), and the mixture was reacted at room temperature for 5-10 hours. The mixture was quenched with sodium bicarbonate, and the pH was adjusted to 8. The mixture was extracted with dichloromethane (3*20 mL). The organic phases were combined, dried over anhydrous sodium sulfate, concentrated, and purified by column chromatography (dichloromethane: methanol = 10: 1) to obtain isomycesmine as a yellow oily liquid (1.4 g, yield 99%).

[0033] In the present invention, nicotinaldehyde and tert-butylsulfenamide are used as raw materials, dichloromethane is used as a solvent, and under the action of pyridinium p-toluenesulfonate, an imine intermediate 1 is reacted, and then an intermediate 2 is obtained by Grignard reaction. The protecting group is removed and the ring is closed under the condition of hydrochloric acid-dioxane to obtain isomycesmine. The rapid synthesis method only needs 3 steps and the conditions are mild, so that the route is safer, environmentally friendly, and convenient for industrial production.

[0034] In the description of this specification, the description with reference to the terms "one embodiment", "example", "specific example", etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner.

[0035] The preferred embodiments of the present invention disclosed above are only used to help illustrate the present invention. The preferred embodiments do not describe all the details in detail, nor do they limit the invention to the specific implementation methods described. Obviously, many modifications and changes can be made according to the content of this specification. This specification selects and specifically describes these embodiments in order to better explain the principles and practical applications of the present invention, so that those skilled in the art can understand and use the present invention well. The present invention is limited only by the claims and their full scope and equivalents.

Claims

1. A rapid synthesis method of isomycesmine, characterized in that: The following steps are involved: S1, dissolving tert-butylsulfenamide in a solvent, adding a desiccant thereto, then adding an additive and nicotinaldehyde, stirring the mixture at room temperature, filtering the resulting reaction mixture through diatomaceous earth, washing with dichloromethane, and concentrating to obtain a yellow oily intermediate 1; S2, the ground magnesium chips are placed in a round-bottom flask, tetrahydrofuran and 2-(2'-bromoethyl)-1,3-dioxane solution are added, and intermittent heating and a catalytic amount of iodine are added to initiate the reaction, and the mixture is stirred at room temperature for 1 to 2 hours to obtain a Grignard reagent, and then the Grignard reagent is added to the intermediate solution at -40°C, and the mixture is stirred at -40°C for 10 to 15 hours. After the reaction is completed, the mixture is quenched and extracted, and concentrated to obtain the intermediate 2; S3, add 4N hydrochloric acid-dioxane solution to the intermediate 2, react at room temperature for 5 to 10 hours, quench with sodium bicarbonate, extract with dichloromethane, combine the organic phases, dry with anhydrous sodium sulfate, concentrate and purify by column chromatography to obtain isomycesine as a yellow oily liquid; The chemical structural formula of the isomycesmine is as follows:

2. A rapid synthesis method of isomycesmine according to claim 1, characterized in that: In the step S1, the stirring reaction time is 15 to 20 hours.

3. A rapid synthesis method of isomycesmine according to claim 1, characterized in that: In the step S1, the solvent is dichloromethane.

4. A rapid synthesis method of isomycesmine according to claim 1, characterized in that: In the step S1, the desiccant is anhydrous magnesium sulfate.

5. A rapid synthesis method of isomycesmine according to claim 1, characterized in that: In the step S1, the desiccant is anhydrous magnesium sulfate.

6. The rapid synthesis method of isomycesmine according to claim 1, characterized in that: In the step S1, the additive is pyridinium p-toluenesulfonate.

7. A rapid synthesis method of isomycesmine according to claim 1, characterized in that: In the step S2, the intermediate liquid is prepared by mixing an intermediate 1 and tetrahydrofuran.

8. The rapid synthesis method of isomycesmine according to claim 1, characterized in that: In the step S2, the molar ratio of the Grignard reagent to the intermediate solution is 3:1.